ANTI-CANCER DRUGS;
ANTI-CANCER DRUG

dc.creatorSanchez, Catherine A.
dc.creatorMercado, Alejandro J.
dc.creatorContreras, Hector R.
dc.creatorCabezas, Juan C.
dc.creatorHuidobro, Christian C.
dc.creatorCastellon, Enrique A.
dc.date2012
dc.date2016-11-29T20:53:59Z
dc.date2022-07-06T14:47:47Z
dc.date2016-11-29T20:53:59Z
dc.date2022-07-06T14:47:47Z
dc.date2012
dc.date.accessioned2023-08-22T06:17:54Z
dc.date.available2023-08-22T06:17:54Z
dc.identifier3090016
dc.identifier3090016
dc.identifier0959-4973
dc.identifierhttps://hdl.handle.net/10533/134306
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8327349
dc.description1
dc.descriptionFONDECYT
dc.descriptioncsanchezn@clc.cl
dc.description9
dc.descriptionFONDECYT
dc.description23
dc.languageeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.relationinfo:eu-repo/grantAgreement/Fondecyt/3090016
dc.relationinfo:eu-repo/semantics/dataset/hdl.handle.net/10533/93477
dc.relationhttps://doi.org/10.1097/CAD.0b013e328355ef88
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titlePharmacoperone in3 enhances the apoptotic effect of leuprolide in prostate cancer cells by increasing the gonadotropin-releasing hormone receptor in the cell membrane
dc.titleANTI-CANCER DRUGS
dc.titleANTI-CANCER DRUG
dc.typeArticulo
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.coveragePHILADELPHIA


Este ítem pertenece a la siguiente institución